Status:
COMPLETED
Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Conditions:
Covid19
Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
Rationale Many patients with coronavirus disease (COVID-19) need hospital admission for oxygen supplementation. A substantial number of patients need intensive care unit (ICU) admission for escalation...
Eligibility Criteria
Inclusion
- COVID-19, confirmed with PCR; and
- Admission to one of the participating ICUs, or an emergency location that serves as an ICU during the pandemic.
Exclusion
- Age \< 18 years
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
1011 Patients enrolled
Trial Details
Trial ID
NCT04719182
Start Date
September 1 2020
End Date
April 1 2021
Last Update
January 10 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam UMC location AMC
Amsterdam, Netherlands, 1105AZ
2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Amsterdam, Netherlands